Status:
COMPLETED
Impedance Sensor Evaluated in Peripheral Artery Disease for Tissue Detection
Lead Sponsor:
Sensome
Conditions:
Peripheral Vascular Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the study is to evaluate the feasibility of the CSGS sensor to differentiate tissues involved in Peripheral Artery Disease (PAD).
Detailed Description
The objective of the study is to evaluate the feasibility of the CSGS sensor to differentiate tissues involved in Peripheral Artery Disease (PAD) Previously the CSGS was used in a clinical study in s...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Subjects with acute and chronic occlusions in the arteries of the lower limbs
- Patients eligible for endovascular interventional procedures
- Written Informed Consent to participate in the study.
Exclusion
- Target Vessel Aneurysm
- Target vessel diameter \<2mm
- Lesions starting at the Common Iliac Artery
- Any subject that is, according to the discretion of the investigator, not eligible for study participation
- Known lactating or confirmation of positive pregnancy test according to site specific standard of care
Key Trial Info
Start Date :
October 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2024
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT06112054
Start Date
October 17 2023
End Date
August 15 2024
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Sint Blasius
Dendermonde, Belgium, 9200